Liothyronine sodium (Mylan Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Liothyronine sodium drug offered from Mylan Pharmaceuticals Inc.. This l-Triiodothyronine [EPC],Triiodothyronine [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Mylan Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | Liothyronine sodium |
| SUBSTANCE NAME: | LIOTHYRONINE SODIUM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | l-Triiodothyronine [EPC],Triiodothyronine [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2016-10-03 |
| END MARKETING DATE: | 0000-00-00 |
Liothyronine sodium HUMAN PRESCRIPTION DRUG Details:
| Item Description | Liothyronine sodium from Mylan Pharmaceuticals Inc. |
| LABELER NAME: | Mylan Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5(ug/1) |
| START MARKETING DATE: | 2016-10-03 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0378-3611_7f56aaf9-505a-48c9-bffc-c054b261d82f |
| PRODUCT NDC: | 0378-3611 |
| APPLICATION NUMBER: | ANDA090326 |
Other LIOTHYRONINE SODIUM Pharmaceutical Manufacturers / Labelers:
